- Patent Title: (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
-
Application No.: US14729700Application Date: 2015-06-03
-
Publication No.: US10064868B2Publication Date: 2018-09-04
- Inventor: S. David Brown , David J. Matthews
- Applicant: MEI Pharma, Inc.
- Applicant Address: US CA San Diego
- Assignee: MEI PHARMA, INC.
- Current Assignee: MEI PHARMA, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D401/14 ; C07D403/04 ; C07D403/14 ; C07D413/14 ; C12N9/12
Abstract:
Provided herein are (alpha-substituted aralkylamino or heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, e.g., a compound of Formula I, and their pharmaceutical compositions, preparation, and use as agents or drugs for treating proliferative diseases.
Public/Granted literature
Information query
IPC分类:
